Prenatal Exposure to Azadiradione Leads to Developmental Disabilities
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04493-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Sudipta Jana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology of Disease Laboratory, Department of Bioscience and Biotechnology, Indian Institute of Technology, Kharagpur, 721302, India. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Developmental Disabilities, Limonins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Azadiradione is a brain-permeable phytochemical present in the seed of an Indian medicinal plant, Azadirachta Indica, well known as neem. Recently, this small bioactive molecule has been revealed to induce the expression of Ube3a, a ubiquitin ligase whose loss and gain of function are associated with two diverse neurodevelopmental disorders. Here, we report that in utero exposure to azadiradione in mice results in severe developmental disabilities. Treatment of a well-tolerated dose of azadiradione into the pregnant dam (at embryonic days 12 and 14) causes a substantial decrease in the body weight of the newborn pups during their early developmental periods along with significant cognitive, motor, and communication deficits and increased anxiety-like behaviors. As the animals grow from adolescence to adulthood, their body weight and many behavioral deficits are gradually restored to normalcy, although the cognitive deficit persists significantly. Biochemical analysis reveals that the azadiradione prenatally exposed mice brain exhibits about 2-3 fold increase in the level of Ube3a at postnatal day 25 along with a significant increase in some of its target proteins linked to synaptic function and plasticity, indicating the enduring effect of the drug on Ube3a expression. The prenatally azadiradione-exposed mice also display increased dendritic spines in the hippocampal and cortical pyramidal neurons. These results suggest that Ube3a might be one of the key players in azadiradione-induced developmental disabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurobiology of Disease Laboratory, Department of Bioscience and Biotechnology, Indian Institute of Technology, Kharagpur, 721302, India.
- Information Processing Laboratory, Department of Electronics and Electrical Communication Engineering, Indian Institute of Technology, Kharagpur, 721302, India.
- Neurobiology of Disease Laboratory, Department of Bioscience and Biotechnology, Indian Institute of Technology, Kharagpur, 721302, India. nihar@iitkgp.ac.in.
Förderung
- Science and Engineering Research Board
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Jana, S., Das, S., Giri, B., Archak, R., Bandyopadhyay, S., & Jana, N. R. (2025). Prenatal Exposure to Azadiradione Leads to Developmental Disabilities. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04493-x
Vancouver
Jana S, Das S, Giri B, Archak R, Bandyopadhyay S, Jana NR. Prenatal Exposure to Azadiradione Leads to Developmental Disabilities. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04493-x
BibTeX
@article{Jana2025,
author = {Jana, Sudipta and Das, Sagarika and Giri, Bhaskarjyoti and Archak, Raghavendra and Bandyopadhyay, Sharba and Jana, Nihar Ranjan},
title = {Prenatal Exposure to Azadiradione Leads to Developmental Disabilities},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04493-x}
}
EUVIMED